Regulatory Toxicology and Pharmacology explained

Regulatory Toxicology and Pharmacology
Discipline:Toxicology and pharmacology
Abbreviation:Regul. Toxicol. Pharmacol.
Publisher:Elsevier on behalf of the International Society of Toxicology & Pharmacology
Frequency:Monthly
History:1981–present
Impact:3.271
Impact-Year:2021
Website:http://www.journals.elsevier.com/regulatory-toxicology-and-pharmacology/
Link1:http://www.sciencedirect.com/science/journal/02732300
Link1-Name:Online access
Oclc:485750423
Lccn:81646304
Coden:RTOPDW
Issn:0273-2300

Regulatory Toxicology and Pharmacology is a monthly peer-reviewed scientific journal which covers legal aspects of toxicological and pharmacological regulations. It is published by Elsevier on behalf of the International Society of Regulatory Toxicology & Pharmacology. The current co-editors-in-chief are Lesa L. Aylward and Martin van den Berg.

Conflicts of interest

In 2002, a group of 45 academics wrote a letter accusing the journal of a concealed pro-industry bias, a possible lack of full and independent peer review, and a failure to disclose conflicts of interest, citing a case in which Gio Batta Gori, then-current editor-in-chief, was paid $30,000 by the Tobacco Institute to write an article later published in the journal dismissing the health risks of secondhand smoke.[1] [2] The letter's coordinator later commented that the journal "reads like an industry trade publication, but it's masked as a peer-reviewed journal" and that it lacked any "credible peer-review process."[3] In response, the journal's publisher implemented a conflict of interest disclosure policy at the journal in January 2003, shortly before the correspondence was published.[1]

Abstracting and indexing

The journal is abstracted and indexed in EMBASE, EMBiology, and Scopus.

According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.031, ranking it 56th out of 87 journals in the category "Toxicology"[4] and 146th out of 254 journals in the category "Pharmacology & pharmacy".[5]

Notes and References

  1. Egilman . David . Correspondence about Publication Ethics and Regulatory Toxicology and Pharmacology . International Journal of Occupational and Environmental Health . 9 . 4 . 286–391 . 2003 . 10.1179/oeh.2003.9.4.386 . 14664493 . Axelson . O. . Balbus . J. M. . Cohen . G. . Davis . D. . Donnay . A. . Doolittle . R. . Duran . B. M. . Egilman . D. . Epstein . S. S. . Goldman . L. . Grandjean . P. . Hansen . E. S. . Heltne . P. . Huff . J. . Infante . P. . Jacobson . M. F. . Joshi . T. K. . Ladou . J. . Landrigan . P. J. . Lee . P. R. . Lockwood . A. H. . MacGregor . G. . Melnick . R. . Messing . K. . Needleman . H. . Ozonoff . D. . Ravanesi . B. . Richter . E. D. . Sass . J. . Schubert . D. . 29 .
  2. Gori . Gio Batta . Mantel . Nathan . August 1991 . Mainstream and environmental tobacco smoke . Regulatory Toxicology and Pharmacology . 14 . 1 . 88–105 . 10.1016/0273-2300(91)90054-Y. 1947248 .
  3. News: . Lila . Guterman . November 20, 2002 . Scientists Accuse Toxicology Journal of Industry Ties, Urge Disclosure of Conflicts of Interest .
  4. Book: 2015 . Journals Ranked by Impact: Toxicology . 2014 Journal Citation Reports . . Sciences . Web of Science .
  5. Book: 2015 . Journals Ranked by Impact: Pharmacology & Pharmacy . 2014 Journal Citation Reports . Thomson Reuters . Sciences . Web of Science .